Enact Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACT research report →
Range $42 – $46
Price Chart
About the company
Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. The company engages in writing and assuming residential mortgage guaranty insurance.
- CEO
- Rohit Gupta
- IPO
- 2021
- Employees
- 419
- HQ
- Raleigh, NC, US
Get TickerSpark's AI analysis on ACT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.94B
- P/E
- 9.38
- Fwd P/E
- 9.27
- PEG
- 0.93
- P/S
- 4.85
- P/B
- 1.19
- EV/EBITDA
- 6.92
- Div Yield
- 1.99%
- Gross Margin
- 89.18%
- Op Margin
- 68.55%
- Net Margin
- 54.13%
- ROE
- 12.75%
- ROIC
- 11.13%
Latest fiscal year · YoY change
- Revenue
- $1.23B+2.4%
- Gross Profit
- $1.12B+19.2%
- Op Income
- $858.84M
- Net Income
- $674.24M-2.0%
- EPS
- $4.54+3.2%
- OCF Growth
- +5.6%
- FCF Growth
- +5.6%
- 52W High
- $50.56
- 52W Low
- $37.03
- 50D MA
- $46.75
- 200D MA
- $44.79
- Beta
- 0.44
- RSI (14)
- 35
- Avg Volume
- 420.76K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Enact delivered solid third-quarter results with $164 million of adjusted operating income, strong credit performance, and a higher 2026 capital return outlook of about $600 million.· November 5, 2026
- Adjusted operating income was $164 million, or $1.19 per diluted share; adjusted ROE was 12% to 12.4%.
- New insurance written was $14 billion and primary insurance in force reached $275 billion, up about 1% year over year.
- Credit stayed strong: the company cited a $37 million reserve release, a 20% loss ratio, and PMIERs sufficiency of 158%.
- Management raised 2026 capital return guidance to approximately $600 million after returning $151 million in the quarter.
- Expense discipline improved, with full-year 2026 expenses now expected at the low end of the $205 million to $210 million range (excluding reorg costs).
Enact reported third-quarter adjusted operating income of $164 million, or $1.19 per diluted share, versus $1.12 per diluted share in the same period last year and $1.26 in the second quarter. Adjusted operating ROE was 12% to 12.4%. New insurance written was $14 billion, flat year over year and down 7% sequentially; primary insurance in force was $275 billion, up $3 billion, or about 1%, year over year. Total net premiums earned were $242 million, down $3 million sequentially and year over year; investment income was $74 million, up 9% year over year. The company recorded a $37 million reserve release and a 20% loss ratio; operating expenses were $50 million with a 21% expense ratio. Management raised 2026 total capital return guidance to approximately $600 million from prior expectations.
Rohit Gupta said the quarter showed the resilience of Enact’s business model, supported by favorable credit performance, a strong balance sheet and disciplined underwriting. He emphasized that the company is focused on selecting “the right risk at the right price,” maintaining prudent standards, and supporting sustainable homeownership. He also highlighted the new 2028 forward quota share agreement, the A.M. Best upgrades, and Enact Re’s continued progress as signs of strategic strength and diversification. His tone was confident and measured, with repeated emphasis on discipline and balance-sheet strength.
Dean Mitchell detailed the quarter’s financial drivers, including $164 million of adjusted operating income, $242 million of net premiums earned, and $74 million of investment income. He said persistency remained elevated at 81%, with 89% of loans below 7% mortgage rates, and noted unrealized investment losses increased by $248 million to $345 million due to rate moves; he called that position materially noneconomic. On credit, he cited 14,400 new delinquencies, a 2.8% delinquency rate, a $37 million reserve release, and a 20% loss ratio. On capital, he said PMIERs sufficiency was 158% or $1.8 billion above requirements, third-party CRT provided $2 billion of PMIERs capital credit, and the company bought back 2.4 million shares for $118 million while paying about $33 million in dividends.
Analysts focused on persistency, buybacks, regulatory changes around mortgage insurance cancellation, reinsurance demand, and credit trends in newer vintages. Management said the FHFA executive order is prospective and too early to predict consumer behavior, though it views appraisal/AVM cancellation mechanics, seasonality, and embedded equity as key considerations. On capital return, Dean Mitchell said buybacks are still attractive at current valuations and are assessed against book value, ex-AOCI, and intrinsic value; on credit, he said 2022–2023 vintages are performing in line with pricing expectations, with future delinquencies likely to rise modestly with seasonality and seasoning. They also said the demand for mortgage credit default risk in reinsurance remains very strong, helping them source a new 2028 quota share on attractive terms.
The bull case from this call is that Enact is still producing solid earnings with very strong credit performance, elevated persistency, and a sturdy capital position. Management is also confident enough to raise 2026 capital return guidance to about $600 million while continuing buybacks, dividends, and long-dated reinsurance coverage on favorable terms.
The main risks discussed were a softer mortgage market, higher rates, and the possibility that delinquency rates drift higher as newer vintages season. Management also flagged uncertainty around the FHFA pilot on mortgage insurance cancellations, and noted that future reserve releases may be smaller as assumptions evolve and the opportunity set narrows.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 19.7%
- Shares Outstanding
- 134.44M
- Float Shares
- 26.46M
of shares held by institutions
251 13F filers
Buy/sell ratio 0.33. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for ACT, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 4.74M | ▼ 45.58K |
| Dimensional Fund Advisors LP | 3.22M | ▲ 115.94K |
| Vanguard Group Inc | 3.14M | ▼ 95.83K |
| Vanguard Portfolio Management LLC | 1.79M | ▲ 26.44K |
| First Trust Advisors LP | 1.67M | ▲ 51.67K |
| Glendon Capital Management LP | 1.30M | 0 |
| State Street Corp | 1.23M | ▼ 24.34K |
| Vanguard Capital Management LLC | 1.23M | ▼ 14.55K |
| Lsv Asset Management | 990.56K | ▼ 14.70K |
| American Century Companies Inc | 987.42K | ▲ 21.74K |
| Geode Capital Management, LLC | 865.70K | ▼ 35.30K |
| Arrowstreet Capital, Limited Partnership | 818.22K | ▼ 59.37K |
Held by 407 ETFs
Biggest fund positions in ACT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 3, 26 | Genworth Holdings, Inc. | sell | 990,583 |
| Oct 1, 26 | McMullen James | other | 887 |
| Oct 1, 26 | McMullen James | other | 253 |
| Oct 1, 26 | McMullen James | other | 887 |
| Sep 30, 26 | Genworth Holdings, Inc. | sell | 762,894 |
| Sep 17, 26 | RESTREPO ROBERT P JR | other | 177 |
| Sep 17, 26 | Addesso Dominic James | other | 308 |
| Sep 17, 26 | Mitchell Hardin Dean | other | 66 |
| Sep 17, 26 | Mitchell Hardin Dean | other | 51 |
| Sep 17, 26 | Mitchell Hardin Dean | other | 32 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ACT coverage
Recent articles, reports, and earnings notes.
No research on ACT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACT report →Dividend Champion, Contender, And Challenger Highlights: Week Of November 22
seekingalpha.com · Nov 20
Aduro Clean Technologies Advances Comparative Life Cycle Assessment of Hydrochemolytic™ Technology with Delphi
globenewswire.com · Nov 17
VivoSim Labs to Showcase Breakthrough Multiparametric NAMkind™ Liver and Intestine Data at the 2026 American College of Toxicology (ACT) Annual Meeting
globenewswire.com · Nov 16
Even $50,000 in Dividend Stocks Pays More Inside a Roth IRA. Here’s How Much More
247wallst.com · Nov 11
VivoSim Labs to Showcase Multiparametric Human 3D Tissue Safety Data at the American College of Toxicology (ACT) 47th Annual Meeting
globenewswire.com · Nov 10
These 4 Overlooked Dividend Stocks Yield Up to 14%. Are They Worth Buying?
247wallst.com · Nov 6
Stock Picks From Seeking Alpha's October 2026 New Analysts
seekingalpha.com · Nov 6
Enact Holdings, Inc. (ACT) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.